NEW YORK, March 21 – Rolling out the latest in an array of recent partnerships, Lynx Therapeutics said Wednesday it had entered into a collaboration with UroGene of Evry, France to use Lynx’s Megasort gene expression technology to discover gene expression patterns associated with prostate cancer, benign prostatic hypertrophy, renal carcinoma, and bladder cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.